Clinical Profile and Outcome of Dilated Cardiomyopathy Children in Banten District Hospital: Retrospective Data of Limited Resources
DOI:
https://doi.org/10.51601/ijhp.v6i1.540Abstract
Pediatric dilated cardiomyopathy (DCM) is a rare and serious disorder, characterized by left or bilateral ventricular dilatation with impaired systolic function, often leading to heart failure. This retrospective study, conducted at Banten District Hospital in Indonesia, aimed to explore the clinical profile, outcomes, and associated factors in pediatric DCM patients from June 2022 to October 2025. A total of 35 children aged 27 days to 18 years were included. Common comorbidities included rheumatic heart disease, congenital heart disease, tuberculosis, myocarditis, and anemia. The study found a significant relationship between malnutrition and adverse outcomes, with 85.7% of patients surviving, while 14.3% died. The most common ejection fraction (EF) score was moderately reduced (30-40%). These findings underline the importance of addressing underlying comorbid conditions such as rheumatic heart disease and nutritional deficiencies. The study calls for a comprehensive approach to managing pediatric DCM, including early detection and treatment of comorbidities, to improve survival outcomes in resource-limited environments.
Downloads
References
[1] E. J. Mejia, S. D. Miyamoto, K. R. Schumacher, and K. Y. Lin, “Dilated Cardiomyopathy,” in Heart Failure in the Child and Young Adult, Elsevier, 2026, pp. 285–297. doi: 10.1016/B978-0-443-13279-7.00009-2.
[2] I. Malinow, D. C. Fong, M. Miyamoto, S. Badran, and C. C. Hong, “Pediatric Dilated Cardiomyopathy: A Review of Current Clinical Approaches and Pathogenesis,” Front. Pediatr., vol. 12, pp. 1–13, Jun. 2024, doi: 10.3389/fped.2024.1404942.
[3] B. Shahim, C. J. Kapelios, G. Savarese, and L. H. Lund, “Global Public Health Burden of Heart Failure: An Updated Review,” Card. Fail. Rev., vol. 9, pp. 1–8, Jul. 2023, doi: 10.15420/cfr.2023.05.
[4] L. Ratner et al., “Sepsis Beyond Bundles: Contextualising Paediatric Care in Resource-Limited Settings Through Situational Analysis,” BMJ Paediatr Open, vol. 9, no. 1, p. e003134, Feb. 2025
[5] A. Seifu, O. Eshetu, D. Tafesse, and S. Hailu, “Admission Pattern, Treatment Outcomes, and Associated Factors For Children Admitted to Pediatric Intensive Care Unit of Tikur Anbessa Specialized Hospital, 2021: A Retrospective Cross-Sectional Study,” BMC Anesthesiol., vol. 22, no. 1, pp. 1–8, Dec. 2022.
[6] R. Dewi et al., “Mortality in Children with Positive SARS-Cov-2 Polymerase Chain Reaction Test: Lessons Learned From A Tertiary Referral Hospital in Indonesia,” Int. J. Infect. Dis., vol. 107, pp. 78–85, Jun. 2021, doi: 10.1016/j.ijid.2021.04.019.
[7] Ş. Arici and F. Akalin, “Prognostic Markers in Pediatric Dilated Cardiomyopathy: Focus on The Neutrophil to Lymphocyte Ratio and The Systemic Inflammatory Index,” Exp. Ther. Med., vol. 30, no. 6, pp. 1–10, Oct. 2025, doi: 10.3892/etm.2025.12994.
[8] S. Kamau, J. Kigo, M. Maina, and J. Gachohi, “External Validation of an Admission Risk Score For Predicting Inpatient Paediatric Mortality in Two Kenyan Public Hospitals,” Wellcome Open Res., vol. 9, p. 732, Dec. 2024, doi: 10.12688/wellcomeopenres.23471.1.
[9] Hardani et al., Buku Metode Penelitian Kualitatif dan Kuantitatif, Cetakan 1., no. Maret. Yogyakarta: CV. Pustaka Ilmu Group Yogyakarta, 2020.
[10] B. Darma, Statistika Penelitian Menggunakan SPSS (Uji Validitas, Uji Reliabilitas, Regresi Linier Sederhana, Regresi Linier Berganda, Uji t, Uji F, R2). Kabupaten Bogor: Guepedia, 2021.
[11] A. Rath and R. Weintraub, “Overview of Cardiomyopathies in Childhood,” Front. Pediatr., vol. 9, pp. 1–9, Jul. 2021, doi: 10.3389/fped.2021.708732.
[12] R. K. Kumar et al., “Contemporary Diagnosis and Management of Rheumatic Heart Disease: Implications for Closing the Gap: A Scientific Statement From the American Heart Association,” Circulation, vol. 142, no. 20, p. e377, Nov. 2020, doi: 10.1161/CIR.0000000000000921.
[13] A. Kodliwadmath, Y. Shrivastava, B. Duggal, D. Khanra, and N. Nanda, “Heart Failure in Tetralogy of Fallot due to Associated Hypertrophic Obstructive Cardiomyopathy,” J. Cardiovasc. Echogr., vol. 31, no. 1, pp. 35–38, Jan. 2021, doi: 10.4103/jcecho.jcecho_93_20.
[14] S. G. Wittekind, H. R. Martinez, C. Villa, M. Bacon, A. M. Hammill, and A. Lorts, “Profound Iron Deficiency Anemia and Irreversible Dilated Cardiomyopathy in a Child,” Case Reports Cardiol., vol. 2019, pp. 1–4, Oct. 2019, doi: 10.1155/2019/7513782.
[15] J. Tao et al., “Associations of Educational Attainment and Traditional Risk Factor Control with Cardiovascular Disease,” Am. J. Prev. Cardiol., vol. 23, no. May, pp. 1–7, 2025, doi: 10.1016/j.ajpc.2025.101031.
[16] X. Li, C. Zhao, M. Liu, W. Zhao, H. Pan, and D. Wang, “Sociodemographic Index–Age Differences in The Global Prevalence of Cardiovascular Diseases, 1990–2019: A Population-Based Study,” Arch. Public Heal., vol. 83, no. 1, pp. 1–12, Jan. 2025, doi: 10.1186/s13690-024-01454-7.
[17] X. N. Shao, Y. N. Jin, Y. J. Sun, W. B. Zhang, and J. L. Cheng, “Evaluation of The Correlation Between Myocardial Fibrosis and Ejection Fraction in Dilated Cardiomyopathy Using Magnetic Resonance T1 Mapping,” Eur. Rev. Med. Pharmacol. Sci., vol. 24, no. 23, pp. 12300–12305, 2020, doi: 10.26355/eurrev_202012_24022.
[18] S. Oliver, S. Lavoie, C. Cunningham, and J. Conway, “Improving Nutrition in Pediatric Heart Failure,” JHLT Open, vol. 10, p. 100379, Nov. 2025, doi: 10.1016/j.jhlto.2025.100379.
[19] K. Lomper, M. Jędrzejczyk, M. Wleklik, and I. Uchmanowicz, “Relationship of Malnutrition and Frailty on Prolonged Stay at The Hospital in Heart Failure Patients,” ESC Hear. Fail., vol. 12, no. 5, pp. 3614–3623, Oct. 2025, doi: 10.1002/ehf2.15390.
[20] B. Xu et al., “Prognosis of Pediatric Dilated Cardiomyopathy: Nomogram and Risk Score Models for Predicting Death/Heart Transplantation,” Children, vol. 12, no. 7, p. 880, Jul. 2025, doi: 10.3390/children12070880.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Amalia Ghanita Herdiana, E.S. Zul Febrianti

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.



















